Modified Vaccinia Ankara

BIOLOGICAL2 trials

Sponsors

Muhimbili University of Health and Allied Sciences, Bavarian Nordic

Conditions

Healthy VolunteersMonkey Pox

Phase 1

Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines

CompletedNCT01461447

Muhimbili University of Health and Allied SciencesHealthy Volunteers

Start: 2012-03-31End: 2012-05-31Updated: 2012-05-24

Phase 2

MVA BN_POX MVA 045

RecruitingPACTR202501779440066

Bavarian NordicMonkey Pox

Start: 2024-10-30Target: 460Updated: 2026-09-14

Related Papers

Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response

PLoS Pathogens2023-05-317 citations